Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eyetech Pharmaceuticals
With
Pfizer
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects of either gender; aged 50 years or greater.
Subfoveal choroidal neovascularization (CNV) due to AMD with predominantly classic lesion composition
Best corrected visual acuity in the study eye between 20/40 and 20/200
You may not be if
Any prior PDT with Visudyne to the study eye
Any previous AMD thermal laser therapy to the study eye
Clareo Health | Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)
